Company / Named in our posts
Amphastar Pharmaceuticals, Inc..
Follow Amphastar Pharmaceuticals, Inc.Amphastar is a bio-pharmaceutical company focused primarily on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products. It also sells insulin API products.[1]
01Deal
Deals on Carrywatch
Every deal that names Amphastar Pharmaceuticals, Inc., and its role in each.
Amphastar Pharmaceuticals, Inc. / Eli Lilly and Company
Amphastar completes BAQSIMI acquisition from Eli Lilly and Company
See deal detailsDeal Web
Amphastar Pharmaceuticals, Inc. and 0 firms it shares a posted deal with, and the path to any other firm.
Financials
5 fiscal years of figures as Amphastar Pharmaceuticals, Inc. reported them.
News
Loading headlines.
Sources
As of 24 Oct 2026.
- 01Amphastar Pharmaceuticals Completes Acquisition of BAQSIMI from Lilly
U.S. Securities and Exchange Commission · Researched 24 Oct 2026
Deal posts naming Amphastar Pharmaceuticals, Inc.:
- P01